MNOV medicinova.com Net earnings per share for the last 12 months

MNOV (MediciNova Inc.) - company brandmark

Current earnings per share over the last 12 months demonstrate a trend where the -0.21 level records fresh values. MediciNova, Inc. (MNOV) quotes already price in development costs and speculative demand. MediciNova, Inc. (MNOV) focuses on ALS and multiple sclerosis therapies via the drug MN-166. Business efficiency is enhanced by AI-driven bioscreening automation and robotics, which eliminate manual labor in drug creation.

MNOV MediciNova, Inc. Earnings per share for the trailing year (07/04/2022 - 11/17/2026)

MediciNova, Inc. - analytical breakdowns and key metrics (MNOV)

- stock price and consensus target price:
Basic company analysis:MediciNova Inc. (MNOV)
Mass-produced product of MediciNova Corp

MediciNova, Inc. (MNOV) diversification of developments in lung and nervous system therapies directly impacts the issuer's financial stability. By analyzing the net profit per share dynamics, an investor can see the actual effectiveness of this strategy. The EPS (TTM) metric mathematically expresses the portion of profit attributable to a single share over the last twelve months. Growth in this indicator confirms the business's ability to generate sustainable income, while a downward curve signals risks of overpaying for capital.

Analysis of competing companies

Jazz Pharmaceuticals Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytokinetics Inc|PTCT (PTC Therapeutics Inc) - Net earnings per share for the last 12 months|Scholar Rock Inc. (SRRK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Centessa Pharmaceuticals|Net earnings per one share for the last twelve months dyne-tx.com DYN|Earnings per share for the last twelve months Edgewise Corp (EWTX)|RAPP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alumis Corp ALMS|Zevra Corp - Earnings per share for the last twelve months|CTNM - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Larimar Therapeutics|CAPR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Entrada TRDA|Net earnings per share for the last 12 months PTHS|Serina (SER) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BTAI|PMN (ProMIS Neurosciences Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Apimeds Pharmaceuticals, Inc. APUS|AEON Biopharma (AEON) - Net earnings per one share for the last twelve months|NLSP - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Bionomics|HUGE (FSD Pharma) - Net earnings per share for the last 12 months|RETA: Earnings per share for the last four quarters